News

The latest UK asthma guidelines1 have identified how Fractional exhaled Nitric Oxide (FeNO) testing fits into the diagnosis and ongoing management of asthma. The guidelines are based on the latest clinical evidence, cost-effectiveness, and cost-effective modelling, so they are strongly...

Asthma  is one of the most common long-term health conditions, so why does access to diagnosis and treatment still depend on where you live, who you see, or even your ethnicity? To mark World Asthma Day, we spoke with Carol...

Bedfont® Scientific Limited promotes FeNO testing for asthma management. Research from Asthma + Lung UK has found a significant rise in Accident and Emergency (A&E) visits from people experiencing breathing issues such as asthma. Asthma + Lung UK is a...

How FeNO testing with the NObreath® can aid an early asthma diagnosis in children. As the world prepares to observe World Health Day on April 7th, 2025, Bedfont® Scientific Limited highlights the importance of early and accurate asthma diagnosis with...

World Health Day is celebrated annually on April 7th to recognise the World Health Organisation’s (WHO) founding in 1948. The day aims to raise awareness about global health issues and efforts to address them. In 2019, 262 million people worldwide...

Local med-tech company Bedfont® Scientific is proud to announce its ranking in the prestigious MegaGrowth 50 awards. Celebrated annually, the MegaGrowth 50 awards recognise the 50 fastest-growing privately owned businesses in Kent and Medway. Bedfont® Scientific, world leaders in breath...